{"disease":{"id":"functional-bowel-irritable-bowel-syndrome","name":"Functional bowel/irritable bowel syndrome","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"dicyclomine","indication_name":"Functional bowel/irritable bowel syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"DICYCLOMINE","company_name":"","drug_phase":"marketed","molecular_target":"Muscarinic receptors","drug_class":"Antispasmodic and anticholinergic (antimuscarinic) agent","quality_score":55,"revenue":null,"mechanism":"Dicyclomine relieves smooth muscle spasm of the gastrointestinal tract via a dual mechanism: anticholinergic effects at acetylcholine receptors and direct smooth muscle relaxation."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05389709","title":"A Pharmacy-based Observational Study to Learn More About Iberogast Advance in the Real-world Setting","phase":"","overall_status":"COMPLETED","enrollment_count":184,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT07388589","title":"Soluble and Osmotic Fibre (SOLOS) Diet for Constipation","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":180,"lead_sponsor_name":"Singapore Institute of Technology","has_results":false},{"nct_id":"NCT06338189","title":"The 5Ad Diet for Functional Bowel Disorders","phase":"NA","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"University of Suffolk","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}